Journal Terms of Use

TERMS OF USE

1. Definitions.
The Journal of Global Drug Policy and Practice web site isoperated by the Institute on Global Drug Policy and the International Scientific and Medical Forum on Drug Abuse on the World Wide Web of the Internet, consisting of information services and content provided by the Institute on Global Drug Policy, the International Scientific and Medical Forum on Drug Abuse, its affiliates and other third parties. “Subscriber” means each person who establishes or accesses a connection to and use of the Journal of Global Drug Policy and Practice Web site.

2. General.
(A) This Agreement, which incorporates by reference other provisions applicable to use of the Journal of Global Drug Policy and Practice Web site, including, but not limited to, supplemental terms and conditions set forth (“Supplemental Terms”) governing the use of certain specific material contained in the Journal of Global Drug Policy and Practice Web site, sets forth the terms and conditions that apply to use of theJournal of Global Drug Policy and Practice Web site by Subscriber. By using the Journal of Global Drug Policy and Practice Web site (other than to read this Agreement for the first time), Subscriber agrees to comply with all of the terms and conditions hereof. The right to use the Journal of Global Drug Policy and Practice Web site is personal to Subscriber and is not transferable to any other person or entity. Subscriber is responsible for all use of Subscriber’s Account (under any screen name or password) and for ensuring that all use of Subscriber’s Account complies fully with the provisions of this Agreement. Subscriber shall be responsible for protecting the confidentiality of Subscriber’s password(s), if any.

(B) The Journal of Global Drug Policy and Practice shall have the right at any time to change or discontinue any aspect or feature of the Web site, including, but not limited to, content, hours of availability, and equipment needed for access or use.

3. Changed Terms.
The Journal of Global Drug Policy and Practice, Inc. shall have the right at any time to change or modify the terms and conditions applicable to Subscriber’s use of the Web site, or any part thereof, or to impose new conditions. Such changes, modifications, additions or deletions shall be effective immediately upon notice thereof, which may be given by means including, but not limited to, posting onthe Journal of Global Drug Policy and Practice Web site, or by any other means by which Subscriber obtains notice thereof. Any use of the Journal of Global Drug Policy and Practice Web site by Subscriber after such notice shall be deemed to constitute acceptance by Subscriber of such changes, modifications or additions.

4. Equipment.
Subscriber shall be responsible for obtaining and maintaining all telephone, computer hardware and other equipment needed for access to and use of the Journal of Global Drug Policy and Practice Web site and all charges related thereto.

5. Subscriber Conduct.
(A) Subscriber shall use the Journal of Global Drug Policy and Practice Web site for lawful purposes only. Subscriber shall not post or transmit through theJournal of Global Drug Policy and Practice Web site any material which violates or infringes in any way upon the rights of others, which is unlawful, threatening, abusive, defamatory, invasive of privacy or publicity rights, vulgar, obscene, profane or otherwise objectionable, which encourages conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any law, or which, without the Journal of Global Drug Policy and Practice’s express prior approval, contains advertising or any solicitation with respect to products or services. Any conduct by a Subscriber that the Journal of Global Drug Policy and Practice’s discretion restricts or inhibits any other Subscriber from using or enjoying the Journal of Global Drug Policy and Practice Web site will not be permitted. Subscriber shall not use the Journal of Global Drug Policy and Practice Web site to advertise or perform any commercial solicitation, including, but not limited to, the solicitation of users to become subscribers of other on-line information services competitive with the Journal of Global Drug Policy and Practice Web site.

(B) The Journal of Global Drug Policy and Practice Web site contains copyrighted material, trademarks and other proprietary information, including, but not limited to, text, software, photos, video, graphics, music and sound, and the entire contents of the Journal of Global Drug Policy and Practice Web site are copyrighted as a collective work under the United States copyright laws. The Journal of Global Drug Policy and Practice owns a copyright in the selection, coordination, arrangement and enhancement of such content, as well as in the content original to it. Subscriber may not modify, publish, transmit, participate in the transfer or sale, create derivative works, or in any way exploit, any of the content, in whole or in part. Subscriber may download copyrighted material for Subscriber’s personal use only. Except as otherwise expressly permitted under copyright law, no copying, redistribution, retransmission, publication or commercial exploitation of downloaded material will be permitted without the express permission of the Journal of Global Drug Policy and Practice and the copyright owner. In the event of any permitted copying, redistribution or publication of copyrighted material, no changes in or deletion of author attribution, trademark legend or copyright notice shall be made. Subscriber acknowledges that it does not acquire any ownership rights by downloading copyrighted material.

(C) Subscriber shall not upload, post or otherwise make available on the Journal of Global Drug Policy and Practice Web site any material protected by copyright, trademark or other proprietary right without the express permission of the owner of the copyright, trademark or other proprietary right and the burden of determining that any material is not protected by copyright rests with Subscriber. Subscriber shall be solely liable for any damage resulting from any infringement of copyrights, proprietary rights, or any other harm resulting from such a submission. By submitting material to any public area of the Journal of Global Drug Policy and Practice Web site, Subscriber automatically grants, or warrants that the owner of such material has expressly granted the Journal of Global Drug Policy and Practice the royalty-free, perpetual, irrevocable, non-exclusive right and license to use, reproduce, modify, adapt, publish, translate and distribute such material (in whole or in part) worldwide and/or to incorporate it in other works in any form, media or technology now known or hereafter developed for the full term of any copyright that may exist in such material. Subscriber also permits any other Subscriber to access, view, store or reproduce the material for that Subscriber’s personal use. Subscriber hereby grants the Journal of Global Drug Policy and Practice the right to edit, copy, publish and distribute any material made available on the Journal of Global Drug Policy and Practice Web site by Subscriber.

(D) The foregoing provisions of Section 5 are for the benefit of the Journal of Global Drug Policy and Practice, its subsidiaries, affiliates and its third party content providers and licensors and each shall have the right to assert and enforce such provisions directly or on its own behalf.

6. Disclaimer of Warranty; Limitation of Liability.
(A) SUBSCRIBER EXPRESSLY AGREES THAT USE OF the Journal of Global Drug Policy and Practice Web site IS AT SUBSCRIBER’S SOLE RISK. NEITHER THE JOURNAL OF GLOBAL DRUG POLICY AND PRACTICE, ITS AFFILIATES NOR ANY OF THEIR RESPECTIVE EMPLOYEES, AGENTS, THIRD PARTY CONTENT PROVIDERS OR LICENSORS WARRANT THAT the Web site WILL BE UNINTERRUPTED OR ERROR FREE; NOR DO THEY MAKE ANY WARRANTY AS TO THE RESULTS THAT MAY BE OBTAINED FROM USE OF the Journal of Global Drug Policy and Practice Web site , OR AS TO THE ACCURACY, RELIABILITY OR CONTENT OF ANY INFORMATION, SERVICE, OR MERCHANDISE PROVIDED THROUGHthe Journal of Global Drug Policy and Practice Web site.

(B) The Journal of Global Drug Policy and Practice Web site IS PROVIDED ON AN “AS IS” BASIS WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, WARRANTIES OF TITLE OR IMPLIED WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OTHER THAN THOSE WARRANTIES WHICH ARE IMPLIED BY AND INCAPABLE OF EXCLUSION, RESTRICTION OR MODIFICATION UNDER THE LAWS APPLICABLE TO THIS AGREEMENT.

(C) THIS DISCLAIMER OF LIABILITY APPLIES TO ANY DAMAGES OR INJURY CAUSED BY ANY FAILURE OF PERFORMANCE, ERROR, OMISSION, INTERRUPTION, DELETION, DEFECT, DELAY IN OPERATION OR TRANSMISSION, COMPUTER VIRUS, COMMUNICATION LINE FAILURE, THEFT OR DESTRUCTION OR UNAUTHORIZED ACCESS TO, ALTERATION OF, OR USE OF RECORD, WHETHER FOR BREACH OF CONTRACT, TORTIOUS BEHAVIOR, NEGLIGENCE, OR UNDER ANY OTHER CAUSE OF ACTION. SUBSCRIBER SPECIFICALLY ACKNOWLEDGES THAT JOURNAL OF GLOBAL DRUG POLICY AND PRACTICE, INC. IS NOT LIABLE FOR THE DEFAMATORY, OFFENSIVE OR ILLEGAL CONDUCT OF OTHER SUBSCRIBERS OR THIRD-PARTIES AND THAT THE RISK OF INJURY FROM THE FOREGOING RESTS ENTIRELY WITH SUBSCRIBER.

(D) IN NO EVENT WILL the JOURNAL OF GLOBAL DRUG POLICY AND PRACTICE OR ANY PERSON OR ENTITY INVOLVED IN CREATING, PRODUCING OR DISTRIBUTING the Journal of Global Drug Policy and Practice Web site, BE LIABLE FOR ANY DAMAGES, INCLUDING, WITHOUT LIMITATION, DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES ARISING OUT OF THE USE OF OR INABILITY TO USE the Journal of Global Drug Policy and Practice Web site. SUBSCRIBER HEREBY ACKNOWLEDGES THAT THE PROVISIONS OF THIS SECTION SHALL APPLY TO ALL CONTENT ONthe Journal of Global Drug Policy and Practice Web site.

(E) IN ADDITION TO THE TERMS SET FORTH ABOVE NEITHER the JOURNAL OF GLOBAL DRUG POLICY AND PRACTICE NOR ITS AFFILIATES, INFORMATION PROVIDERS OR CONTENT PARTNERS SHALL BE LIABLE REGARDLESS OF THE CAUSE OR DURATION, FOR ANY ERRORS, INACCURACIES, OMISSIONS, OR OTHER DEFECTS IN, OR UNTIMELINESS OR UNAUTHENTICITY OF, THE INFORMATION CONTAINED WITHIN the Journal of Global Drug Policy and Practice Web site, OR FOR ANY DELAY OR INTERRUPTION IN THE TRANSMISSION THEREOF TO THE USER, OR FOR ANY CLAIMS OR LOSSES ARISING THEREFROM OR OCCASIONED THEREBY. NONE OF THE FOREGOING PARTIES SHALL BE LIABLE FOR ANY THIRD-PARTY CLAIMS OR LOSSES OF ANY NATURE, INCLUDING, BUT NOT LIMITED TO, PUNITIVE OR CONSEQUENTIAL DAMAGES.

7. Monitoring.
The Journal of Global Drug Policy and Practice shall have the right to monitor, but not obligation to monitor, the content of the Journal of Global Drug Policy and Practice Web site, including forums, to determine compliance with this Agreement and any operating rules established by the Journal of Global Drug Policy and Practice and to satisfy any law, regulation or authorized government request. The Journal of Global Drug Policy and Practice shall have the right in its sole discretion to edit, refuse to post or remove any material submitted to or posted onthe Journal of Global Drug Policy and Practice Web site. Without limiting the foregoing, the Journal of Global Drug Policy and Practice shall have the right to remove any material that Journal of Global Drug Policy and Practice, in its sole discretion, finds to be in violation of the provisions hereof or otherwise objectionable.

8. Indemnification.
Subscriber agrees to defend, indemnify and hold harmless the Journal of Global Drug Policy and Practice, its affiliates and their respective directors, officers, employees and agents from and against all claims and expenses, including attorneys’ fees, arising out of the use of the Journal of Global Drug Policy and Practice Web site by Subscriber or Subscriber’s Account.

9. Termination.
Either the Journal of Global Drug Policy and Practice or Subscriber may terminate this Agreement at any time. Without limiting the foregoing, the Journal of Global Drug Policy and Practice shall have the right to immediately terminate Subscriber’s Account in the event of any conduct by Subscriber which the Journal of Global Drug Policy and Practice, in its sole discretion, considers to be unacceptable, or in the event of any breach by Subscriber of this Agreement. The provisions of Sections 5(B), 5(C), 5(D), 6, 8, 10 and this Section 9 shall survive termination of this Agreement.

10. Trademarks.
The Journal of Global Drug Policy and Practice, the Institute on Global Drug Policy, the International Scientific and Medical Forum on Drug Abuse, the Journal of Global Drug Policy and Practice Web site and each of their logos are trademarks of Drug Free America Foundation, Inc. All rights reserved. All other trademarks appearing on the Journal of Global Drug Policy and Practice Web site are the property of their respective owners.

11. Third Party Content.
The Journal of Global Drug Policy and Practice is a distributor (and not a publisher) of content supplied by third parties and Subscribers. Accordingly, the Journal of Global Drug Policy and Practice has no editorial control over such content. Any opinions, advice, statements, services, or other information or content expressed or made available by third parties, including information providers, Subscribers or any other user of the Journal of Global Drug Policy and Practice Web site, are those of the respective author(s) or distributor(s) and not of the Journal of Global Drug Policy and Practice. Neither the Journal of Global Drug Policy and Practice nor any third-party provider of information guarantees the accuracy, completeness, or usefulness of any content, nor its merchantability or fitness for any particular purpose. (Refer to Section 6 above for the complete provisions governing limitation of liabilities and disclaimers of warranty.)

In some instances, the content available through the Journal of Global Drug Policy and Practice Web site represents the opinions and judgments of the respective information provider, Subscriber, or other user not under contract with the Journal of Global Drug Policy and Practice. The Journal of Global Drug Policy and Practice neither endorses nor is responsible for the accuracy or reliability of any opinion, advice or statement made on the Journal of Global Drug Policy and Practice Web site by anyone other than authorized Journal of Global Drug Policy and Practice employee spokespersons while acting in their official capacities. Under no circumstances will the Journal of Global Drug Policy and Practice be liable for any loss or damage caused by a Subscriber’s reliance on information obtained through the Journal of Global Drug Policy and Practice Web site. It is the responsibility of Subscriber to evaluate the accuracy, completeness or usefulness of any information, opinion, advice or other content available through the Journal of Global Drug Policy and Practice Web site. Please seek the advice of professionals, as appropriate, regarding the evaluation of any specific information, opinion, advice or other content.

12. Miscellaneous.
This Agreement and any operating rules for the Journal of Global Drug Policy and Practice Web site established by the Institute on Global Drug Policy and the International Scientific and Medical Forum on Drug Abuse constitute the entire agreement of the parties with respect to the subject matter hereof, and supersede all previous written or oral agreements between the parties with respect to such subject matter. This Agreement shall be construed in accordance with the laws of the State of Florida , without regard to its conflict of laws rules. No waiver by either party of any breach or default hereunder shall be deemed to be a waiver of any preceding or subsequent breach or default. The section headings used herein are for convenience only and shall not be given any legal import.

13. Copyrights and Copyright Agent.
The Journal of Global Drug Policy and Practice respects the rights of all copyright holders and in this regard, the Journal of Global Drug Policy and Practice has adopted and implemented a policy that provides for the termination in appropriate circumstances of subscribers and account holders who infringe the rights of copyright holders. If you believe that your work has been copied in a way that constitutes copyright infringement, please provide the Journal of Global Drug Policy and Practice’s Copyright Agent the following information required by the Online Copyright Infringement Liability Limitation Act of the Digital Millennium Copyright Act, 17 U.S.C. ¤ 512:

A physical or electronic signature of a person authorized to act on behalf of the owner of an exclusive right that is allegedly infringed;

Identification of the copyright work claimed to have been infringed, or, if multiple copyrighted works at a single online site are covered by a single notification, a representative list of such works at that site;

Identification of the material that is claimed to be infringing or to be the subject of infringing activity and that is to be removed or access to which is to be disabled, and information reasonably sufficient to permit us to locate the material;

Information reasonably sufficient to permit us to contact the complaining party;

A statement that the complaining party has a good-faith belief that use of the material in the manner complained of is not authorized by the copyright owner, its agent, or the law; and

A statement that the information in the notification is accurate, and under penalty of perjury, that the complaining party is authorized to act on behalf of the owner of an exclusive right that is allegedly infringed.

For copyright inquiries under the Digital Millennium Copyright Act please contact:

Managing Editor,
Journal of Global Drug Policy and Practice
333 3rd Ave N, Suite 200
St. Petersburg , FL 33701
Phone: (727) 828-0211
Fax: (727) 828-0210

WordPress Lightbox